4
Changes in Ownership
Spero Therapeutics, Inc. Filed Acc 0000899243-22-031497
Director acquired 15,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tregoning Kathleen Director | 2022-09-15 | Grant or award | +15,000 | 15,000 | D |
Loading xslF345X03/doc4.xml…